Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis PERSEUS phase 3 study in primary progressive multiple sclerosis did not meet its primary endpoint in delaying time to ...
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Ongoing discussions with the FDA regarding nrSPMS application have indicated ...
The Healthy @Reader's Digest on MSN
Intensity vs. Amount: This Type of Workout Is More Likely To Lengthen Lifespan, Found Recent Study
Is it just showing up, or how hard you muscle it out? Sports science research studying American adults is proposing an answer ...
Fitgurú on MSN
Forget the hours: This specific type of workout is proven to extend your lifespan, new study finds
Scientists have finally settled the debate on whether you should workout longer or harder to protect your heart. The answer ...
A $1 million grant will support a study seeing if a program combining cognitive training and exercise prevents falls in older adults with MS.
Falls are major public health problems, affecting an estimated 26.5% of older adults globally. They result from dysfunction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback